Search Within

Alan Loh Ho

Formats
  1. Journal Article (111)
  2. Meeting Abstract (104)
  3. Review (7)
  4. Editorial (4)
  5. Guidelines (4)
  6. Research Letter (4)
  7. Book Section (2)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (237)
  2. Head and Neck Service (237)
  3. Solid Tumor Oncology Division (237)
  4. Department of Pathology and Laboratory Medicine (93)
  5. Surgery (78)
  6. GSK Faculty (69)

More Groups

People
  1. David Pfister (89)
  2. Eric Sherman (84)
  3. Lara Dunn (53)
  4. Nora Katabi (48)
  5. Nancy Lee (42)
  6. Sofia Haque (40)

More People

Years
  1. 2025 (5)
  2. 2024 (25)
  3. 2023 (26)
  4. 2022 (23)
  5. 2021 (18)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (73)
  2. Annals of Oncology (20)
  3. International Journal of Radiation Oncology, Biology, Physics (14)
  4. Cancer Research (10)
  5. Clinical Cancer Research (8)
  6. Journal of the National Comprehensive Cancer Network (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (75)
  2. Elsevier Inc. (27)
  3. Oxford University Press (24)
  4. American Association for Cancer Research (23)
  5. Springer (11)
  6. Wiley Blackwell (11)

More Publishers

Results (237)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer
    Review

    Cracchiolo, J. R.; Starc, M. T.; Wong, R. J.; Ho, A.; Ganly, I.; Pfister, D. G.; Lee, N.; Wong, W.; Tam, K.; Cohen, M. A.; more...
    Oral Oncology (2025)

    Fulltext@MSK | Save
  • Sympathetic axonogenesis promotes adenoid cystic carcinoma progression
    Journal Article

    Chen, C. H.; Reva, B.; Katabi, N.; Wizel, A.; Xu, H.; Ho, A. L.; Morris, L. G. T.; Bakst, R. L.; Parikh, A. S.; Drier, Y.; more...
    Journal of Experimental Medicine (2025)

    Fulltext@MSK | Save
  • Targeted RNA sequencing in diagnostically challenging head and neck carcinomas identifies novel MON2::STAT6, NFATC2::NUTM2B, POC5::RAF1, and NSD3::NCOA2 gene fusions
    Journal Article

    Chu, Y. H.; Katabi, N.; Sukhadia, P.; Mullaney, K. A.; Zaidinski, M.; Cracchiolo, J. R.; Xu, B.; Ghossein, R. A.; Ho, A. L.; DiNapoli, S. E.; more...
    Histopathology (2025)

    Fulltext@MSK | Save
  • Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer
    Journal Article

    Konda, B.; Sherman, E. J.; Massarelli, E.; Nieva, J.; Muzaffar, J.; Morris, J. C., III; Ryder, M.; Ho, A. L.; Agulnik, M.; Wei, L.; more...
    Journal of Clinical Endocrinology and Metabolism (2025)

    Fulltext@MSK | Save
  • Melanoma-associated antigen A4: A cancer/testis antigen as a target for adoptive T-cell receptor T-cell therapy
    Review

    Knafler, G.; Ho, A. L.; Moore, K. N.; Pollack, S. M.; Navenot, J. M.; Sanderson, J. P.
    Cancer Treatment Reviews (2025)

    Fulltext@MSK | Save
  • Phase II study of PDR001 in combination with MAPK pathway inhibitors in patients with radioactive-refractory differentiated thyroid cancer (DTC)
    Meeting Abstract

    Wong, W.; Sherman, E. J.; Kriplani, A.; Michel, L.; Zhi, I.; Hung, T. K. W.; Dunn, L.; Grewal, R. K.; Krishnamoorthy, G.; Ostrovnaya, I.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Cracchiolo, J.; Ho, A. L.; Sherman, E. J.; Ganly, I.; Ghossein, R.; Cohen, M.; Wong, W.; Desilets, A.; Michel, L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy of HB-200 in patients with detectable TTMV-HPV DNA after definitive treatment for HPV16 + HNSCC
    Meeting Abstract

    Ho, A. L.; Riaz, N.; Pfister, D.; Wong, R.; Lee, N.; Sherman, E. J.; Haque, S.; Ostrovnaya, I.; Wong, W.
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II trial of ozuriftamab vedotin (BA3021), a conditionally active biologic (CAB)-ROR2-ADC, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
    Meeting Abstract

    Wong, W.; Adkins, D. R.; Misleh, J. G.; Lorch, J.; Grewal, J. S.; Russell, J.; Cetnar, J.; Ho, A. L.; Chen, K.; Aysola, K.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Phase II randomized trial of chemotherapy followed by surgery and PORT versus surgery and PORT for organ preservation of T3 and T4a (selected T4b) sinonasal squamous cell carcinoma (SNC): A trial of the ECOG-ACRIN cancer research group (EA3163)
    Meeting Abstract

    Saba, N. F.; Flamand, Y.; Lin, D. T.; Chung, C. H.; McDonald, M. W.; Flampouri, S.; Khan, S. A.; Snyderman, C. H.; Hanna, E.; El-Sayed, Y. H.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save